Know Cancer

or
forgot password
  • cancer clinical trials in oklahoma

  • Comparison of Combination Chemotherapy Regimens With or Without Cetuximab in Treating Patients Who Have Undergone Surgery For Stage III Colon Cancer
    Cancer Care Associates

    Trial Locations
    Cancer Care Associates
    Natalie W Bryant Cancer Center
    Adenocarcinoma of the Colon, Stage III Colon Cancer
    Celecoxib in Treating Patients With Cervical Intraepithelial Neoplasia
    Cancer Care Associates - Saint Francis Campus
    Tulsa, Oklahoma 74136-1929
    Cervical Cancer, Precancerous Condition
    Study of Late-Occurring Complications in Childhood Cancer Survivors
    University of Oklahoma Health Sciences Center
    Oklahoma City, Oklahoma 73104
    Cancer Survivor, Cardiovascular Complications, Hematopoietic/Lymphoid Cancer, Unspecified Childhood Solid Tumor, Protocol Specific
    Exemestane in Preventing Cancer in Postmenopausal Women at Increased Risk of Developing Breast Cancer
    University of Oklahoma
    Oklahoma City, Oklahoma 73190
    Breast Cancer
    Comparison of Radiation Therapy Regimens in Combination With Chemotherapy in Treating Young Patients With Newly Diagnosed Standard-Risk Medulloblastoma
    Oklahoma University Cancer Institute
    Oklahoma City, Oklahoma 73104
    Brain Tumor, Central Nervous System Tumor
    Study of Talabostat and Rituximab in Advanced Chronic Lymphocytic Leukemia (CLL)
    Cancer Care Associates/Oklahoma City

    Trial Locations
    Cancer Care Associates/Oklahoma City
    Cancer Care Associates--Tulsa
    Chronic Lymphocytic Leukemia
    PANVACâ„¢-VF Vaccine for the Treatment of Metastatic Pancreatic Cancer After Failing a Gemcitabine-Containing Regimen
    University of Oklahoma Health Science Center
    Oklahoma City, Oklahoma 73104
    Pancreatic Cancer
    DNA Variations in the Gene in Young Patients With Wilms' Tumor
    Children's Hospital at Oklahoma University Medical Center

    Trial Locations
    Children's Hospital at Oklahoma University Medical Center
    CCOP - Oklahoma
    Natalie Warren Bryant Cancer Center
    Kidney Cancer
    Fluorouracil, Leucovorin, and Oxaliplatin With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II or Stage III Colon Cancer
    Cleo Craig Cancer Research Clinic

    Trial Locations
    Cleo Craig Cancer Research Clinic
    Oklahoma University Medical Center
    Cancer Care Associates - Mercy Campus
    Natalie Warren Bryant Cancer Center at St. Francis Hospital
    LaFortune Cancer Center at St. John Medical Center
    Colorectal Cancer
    Radiation Therapy, Temozolomide, and Irinotecan in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
    Natalie Warren Bryant Cancer Center at St. Francis Hospital
    Tulsa, Oklahoma 74136
    Brain and Central Nervous System Tumors
    Radiation Therapy in Treating Women Who Have Undergone Surgery For Ductal Carcinoma In Situ or Stage I or Stage II Breast Cancer
    Natalie Warren Bryant Cancer Center at St. Francis Hospital
    Tulsa, Oklahoma 74136
    Breast Cancer
    Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
    Oklahoma University Cancer Institute

    Trial Locations
    Oklahoma University Cancer Institute
    Natalie Warren Bryant Cancer Center at St. Francis Hospital
    Leukemia
    Paclitaxel or Polyglutamate Paclitaxel or Observation in Treating Patients With Stage III or Stage IV Ovarian Epithelial or Peritoneal Cancer or Fallopian Tube Cancer
    Cancer Care Associates-Yale
    Tulsa, Oklahoma 74136-1929
    Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer
    Capecitabine, Oxaliplatin, and Radiation Therapy in Treating Patients Who Are Undergoing Surgery for Stage I Rectal Cancer
    Integris Oncology Services

    Trial Locations
    Integris Oncology Services
    Natalie Warren Bryant Cancer Center at St. Francis Hospital
    Colorectal Cancer
    Combination Chemotherapy, PEG-Interferon Alfa-2b, and Surgery in Treating Patients With Osteosarcoma
    University of Oklahoma Health Sciences Center
    Oklahoma City, Oklahoma 73104
    Localized Osteosarcoma, Metastatic Osteosarcoma
    Pelvic Exenteration in Treating Patients With Recurrent Cervical Cancer
    Oklahoma University Cancer Institute

    Trial Locations
    Oklahoma University Cancer Institute
    Cancer Care Associates - Saint Francis Campus
    Cervical Cancer
    Oxaliplatin, Leucovorin, and Fluorouracil With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II Colon Cancer
    Cancer Care Associates

    Trial Locations
    Cancer Care Associates
    Natalie W Bryant Cancer Center
    Saint John Medical Center
    Adenocarcinoma of the Colon, Stage II Colon Cancer
    Proteomic Profiling in Diagnosing Ovarian Cancer in Patients Who Are Undergoing Surgery for an Abnormal Pelvic Mass
    Cancer Care Associates - Midtown Tulsa
    Tulsa, Oklahoma 74104
    Fallopian Tube Cancer, Ovarian Cancer
    Paclitaxel and Radiation Therapy With or Without Trastuzumab in Treating Patients Who Have Undergone Surgery for Bladder Cancer
    University of Oklahoma Health Sciences Center
    Oklahoma City, Oklahoma 73104
    Stage I Bladder Cancer, Stage II Bladder Cancer, Stage III Bladder Cancer, Transitional Cell Carcinoma of the Bladder
    Cisplatin and Radiation Therapy With or Without Tirapazamine in Treating Patients With Cervical Cancer
    University of Oklahoma Health Sciences Center

    Trial Locations
    University of Oklahoma Health Sciences Center
    Cancer Care Associates-Yale
    Cancer Care Associates-Midtown
    Cervical Adenocarcinoma, Cervical Adenosquamous Cell Carcinoma, Cervical Squamous Cell Carcinoma, Stage IB Cervical Cancer, Stage IIA Cervical Cancer, Stage IIB Cervical Cancer, Stage III Cervical Cancer, Stage IVA Cervical Cancer
    Carboplatin and Paclitaxel With or Without Bevacizumab in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Primary Peritoneal Cancer, or Fallopian Tube Cancer
    Cancer Care Associates-Midtown
    Tulsa, Oklahoma 74104
    Brenner Tumor, Fallopian Tube Cancer, Ovarian Clear Cell Cystadenocarcinoma, Ovarian Endometrioid Adenocarcinoma, Ovarian Mixed Epithelial Carcinoma, Ovarian Mucinous Cystadenocarcinoma, Ovarian Serous Cystadenocarcinoma, Ovarian Undifferentiated Adenocarcinoma, Primary Peritoneal Cavity Cancer, Stage III Ovarian Epithelial Cancer, Stage IV Ovarian Epithelial Cancer
    Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer
    Cancer Centers of Southwest Oklahoma, LLC - Lawton

    Trial Locations
    Cancer Centers of Southwest Oklahoma, LLC - Lawton
    Cancer Care Associates - Norman
    Oklahoma University Cancer Institute
    Cancer Care Associates - Mercy Campus
    Cancer Care Associates at Troy and Dollie Smith Cancer Center
    Colorectal Cancer
    Study to Assess Compliance With Long-Term Mercaptopurine Treatment in Young Patients With Acute Lymphoblastic Leukemia in Remission
    Natalie Warren Bryant Cancer Center at St. Francis Hospital
    Tulsa, Oklahoma 74136
    Leukemia
    ErbB2 Over-expressing Metastatic Breast Cancer Study Using Paclitaxel, Trastuzumab, and Lapatinib
    GSK Investigational Site
    Oklahoma City, Oklahoma 73112
    Neoplasms, Breast
    Hormone Therapy and Radiation Therapy or Hormone Therapy and Radiation Therapy Followed by Docetaxel and Prednisone in Treating Patients With Localized Prostate Cancer
    Oklahoma University Cancer Institute

    Trial Locations
    Oklahoma University Cancer Institute
    Natalie Warren Bryant Cancer Center at St. Francis Hospital
    Prostate Cancer
    Zoledronate or Observation in Maintaining Bone Mineral Density in Patients Who Are Undergoing Surgery to Remove Both Ovaries
    Cancer Care Associates - Saint Francis Campus
    Tulsa, Oklahoma 74136-1929
    Hereditary Breast/Ovarian Cancer (brca1, brca2), Osteoporosis, Ovarian Cancer
    ABI-007 in Treating Patients With Persistent or Recurrent Cervical Cancer
    Oklahoma University Cancer Institute

    Trial Locations
    Oklahoma University Cancer Institute
    Cancer Care Associates - Saint Francis Campus
    Cervical Cancer